Replies to post #146336 on Biotech Values

[DewDiligence]

Re: PFE sales in emerging markets

It is a start, but +36% YoY from a small base isn't blockbuster, imho.

The base is not small. In 2Q12, PFE had $10.5B of annualized sales in emerging markets.

It will take a number of years before the emerging markets really makes a difference in their top line growth..

Wrong. It’s making a difference right now.

p.s. PFE is currently trading at its highest price since 2007.